Gcfree, Inc.

Newton, MA 02468

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.07MM
First Award Date 03/07/08
Most Recent Award Date 09/19/16

Key Personnel

Last Name Name Awards Contact
DA SILVA, ANA PAULA GALVAO 1
Muchmore Elaine A Muchmore 2
Hurtado-Ziola Nancy Hurtado-Ziola 1
EAVARONE DAVID EAVARONE 1

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/16 - 09/18/18

Within a tumor there are two main cell types: mature cancer cells comprising the majority of a tumor and a small population of especially lethal ?cancer stem cell (CSCs) resistant to treatment that can cause cancer relapse. Thus, novel strategies are needed to target and kill not only the majority of mature cancer cells but also the CSCs in orde...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 05/01/15 - 10/31/15

DESCRIPTION (provided by applicant): The capacity to distinguish normal from malignant cells in a consistent and reliable fashion remains an important but often elusive goal for cancer therapy. Aberrant forms of glycosylation been described in numerous human cancers, identifying glycans as an entirely novel class of tumor-associated antigens su...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/30/09 - 12/31/11

DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a chronic inflammatory disease marked by symmetric polyarthritis and joint destruction. While a specific cause is not known, antibodies are thought to play a role in this disease. RA has also been associated with heterophile "Hanganutziu-Deicher" (HD) antibodies, which were first ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-07-281
Budget: 09/30/09 - 03/06/11

DESCRIPTION (provided by applicant): GcFree, Inc. is founded on recent discoveries and patents about a sialic acid called Neu5Gc, which is present in large amounts on the surface of cells of most animals, but not humans. Potentially immunogenic Neu5Gc from exogenous sources (e.g., animal- derived reagents used for making biotherapeutic products)...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-07-81
Budget: 03/07/08 - 03/06/10

DESCRIPTION (provided by applicant): GcFree, Inc. is founded on recent discoveries and patents about a sialic acid called Neu5Gc, which is present in large amounts on the surface of cells of most animals, but not humans. Potentially immunogenic Neu5Gc from exogenous sources (e.g., animal- derived reagents used for making biotherapeutic products)...